参考文献/References:
[1]杨丽娟.子宫内膜异位致不孕的原因分析及其处理对策[J].中国继续医学教育,2016,8(14):96-97.[2]李苗,邸媛媛,邓清华,等.子宫内膜异位症并不孕患者血清内分泌激素水平及自身免疫抗体分析[J].中国妇幼保健,2018,33(14):3274-3276.[3]付楝.补肾调经汤内服对子宫内膜异位症体液免疫及异位子宫内膜的影响[J].陕西中医,2016,37(8):1051-1052.[4]辛慧静,马春芹.腹腔镜和开腹手术治疗子宫内膜异位症伴不孕患者的疗效比较[J].实用妇科内分泌杂志,2018,5(8):103-104.[5]郝玉珍,胡西凤,冀秋凤.腹腔镜下囊肿剥除术和阴道超声引导下囊肿穿刺术治疗卵巢子宫内膜异位囊肿的疗效观察[J].西北国防医学杂志,2016,37(12):847-848.[6]武明娟,陈燕荣,车海沙.腹腔镜联合GnRHa对不同程度子宫内膜异位症性不孕患者妊娠率的影响[J].贵州医药,2019,43(5):735-737.[7]王宁.生长激素对子宫内膜异位症患者活性氧簇、总抗氧化能力的影响[D].石家庄：河北医科大学,2020.[8]韩亚,辛丹平.自拟中药补肾活血方联合米非司酮胶囊治疗子宫内膜异位症合并不孕疗效分析及不良反应观察[J].辽宁中医杂志,2016,43(12):2595-2597.[9]付蒙,吕晓杰.地屈孕酮片联合中药人工周期治疗子宫内膜异位症致不孕疗效观察[J].中国药业,2017,26(11):44-47.[10]杨璞玉,马彩虹.子宫内膜异位症合并不孕患者控制性促排卵方案的选择[J].中华生殖与避孕杂志,2019,39(5):409-412.[11]Rossi AC,Prefumo F.The effects of surgery for endometriosis on pregnancy outcomes following in vitro fertilization and embryo transfer:A systematic review and meta-analysis[J].Arch Gynecol Obstet,2016,294(3):647-655.[12]徐冰.金铃子散合四逆散加减治疗子宫内膜异位症致不孕临床研究[J].陕西中医,2017,38(5):627-629.[13]秦庆双,高美华.子宫内膜异位症与免疫不孕的相关性研究[J].山东医学高等专科学校学报,2016,38(1):59-61.[14]王玲玲,宋影.腹腔镜下治疗不孕症合并子宫内膜异位症的妊娠结局及相关因素分析[J].中国妇幼保健,2017,32(15):3588-3591.[15]谭兴民,陈淑涛,赵晓贞,等.腹腔镜手术联合促性腺激素释放激素激动剂治疗Ⅰ-Ⅱ期子宫内膜异位症伴不孕临床疗效[J].湖南师范大学学报(医学版),2017,14(2):149-151.[16]周明,陈丹丹,王丽娜,等.腹腔镜联合GnRH-a治疗Ⅰ期子宫内膜异位症不孕的临床研究[J].腹腔镜外科杂志,2016,21(12):948-950.[17]亓文博,张明乐,黄向华.腹腔镜保守性手术联合药物治疗中、重度子宫内膜异位症及地诺孕素治疗复发性子宫内膜异位症性盆腔痛的疗效分析[J].中华生殖与避孕杂志,2017,37(5):384-388.[18]李卫梅.地诺孕素联合腹腔镜手术治疗中重度子宫内膜异位症合并不孕的临床分析[J].江西西药,2021,56(7):1047-1048,1071.[19]苏胜红.子宫内膜异位症合并不孕患者腹腔镜术后联合药物治疗对妊娠结局的影响[J].中国计划生育和妇产科,2018,10(1):32-36.[20]黄志欣,李隽,黄博,等.腹腔镜联合促性腺激素释放激素激动剂治疗子宫内膜异位症伴不孕症的疗效观察[J].现代生物医学进展,2017,17(1):70-72.[21]刘耀婷.补肾活血方对子宫内膜异位症不孕患者内膜容受性影响的临床研究[D].晋中：山西中医药大学,2018.[22]吴玉雯.子宫内膜异位症合并不孕症患者术后自然妊娠率的影响因素研究[D].芜湖：皖南医学院,2019.[23]刘丹,梁新.新育龄期子宫内膜异位症合并不孕症患者临床特征及腹腔镜术后辅助生殖妊娠结局影响因素分析[J].陕西医学杂志,2021,50(4):409-412,420.[24]鲜恩英,李雪琴,黄莉莉.益气补肾化瘀法周期性治疗子宫内膜异位症伴不孕的临床疗效[J].中华中医药学刊,2018,36(6):1471-1474.[25]贺希.补肾活血序贯疗法治疗子宫内膜异位症性不孕的临床研究[D].南京:南京中医药大学,2016.[26]杨琪.温肾化瘀法治疗肾虚血瘀型子宫内膜异位性疾病的临床观察[D].北京:北京中医药大学,2017.[27]陈敏红.曾诚补肾活血调周法治疗术后内异症不孕的经验[J].江苏中医药,2017,49(3):23-25.[28]李艳青,林晓华,许志娟,等.莪术消癥丸治疗气滞血瘀型子宫内膜异位症临床疗效分析[J].中日友好医院学报,2016,30(1):20-22.[29]沈群,陆菁.针灸治疗子宫内膜异位症临床观察[J].上海针灸杂志,2017,36(6):711-714.[30]谢春丽,赵星,朱兰妃.热敏灸联合腹腔镜手术治疗子宫内膜异位症不孕症疗效观察[J].上海针灸杂志,2021,40(5):576-580.[31]王娇.定坤丹联合腹腔镜治疗血瘀型子宫内膜异位症性不孕的临床研究[D].晋中：山西中医药大学,2021.[32]蒋袁园,汤建利.腹腔镜手术配合中药治疗子宫内膜异位症伴不孕临床观察[J].新中医,2017,49(1):109-111.[33]李雪梅,何春妮.地屈孕酮治疗卵巢子宫内膜异位症术后的临床研究[J].吉林医学,2019,40(10):2244-2246.[34]周晓红,傅文君,王宝娣,等.雷公藤多苷联合孕三烯酮对子宫内膜异位症及血清细胞因子表达的临床研究[J].中国中药杂志,2016,41(18):3478-3482.
相似文献/References:
[1]刘秀娟,马艳华,马月巧,等.腹腔镜联合罗氏内异方治疗中、重度子宫内膜异位症
相关不孕的疗效观察[J].医学信息,2018,31(13):77.[doi:10.3969/j.issn.1006-1959.2018.13.022]
LIU Xiu-juan,MA Yan-hua,MA Yue-qiao,et al.Observation on the Curative Effect of Laparoscopic Combined with Luo’s Internal Prescription for Severe Endometriosis Related Infertility[J].Medical Information,2018,31(09):77.[doi:10.3969/j.issn.1006-1959.2018.13.022]
[2]孔俊沣,钟 雯,刘 嵩,等.MRI对卵巢子宫内膜异位囊肿的诊断价值[J].医学信息,2022,35(11):165.[doi:10.3969/j.issn.1006-1959.2022.11.044]
KONG Jun-feng,ZHONG Wen,LIU Song,et al.The Diagnostic Value of MRI in Ovarian Endometriotic Cyst[J].Medical Information,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.11.044]
[3]李德君,李慧君.来曲唑联合苍附导痰汤治疗多囊卵巢综合征不孕症患者的
临床观察[J].医学信息,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
LI De-jun,LI Hui-jun.Clinical Observation of Letrozole Combined with Cangfu Daotan Decoction in the Treatment of Infertility Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(09):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
[4]王红红.纵隔子宫IVF/ICSI-ET助孕前行宫腔镜下子宫纵隔切除手术对妊娠结局的影响[J].医学信息,2018,31(19):102.[doi:10.3969/j.issn.1006-1959.2018.19.030]
WANG Hong-hong.Effect of Hysteroscopic Uterine Mediastinal Resection on Pregnancy Outcome before IVF/ICSI-ET in Uterus Septus[J].Medical Information,2018,31(09):102.[doi:10.3969/j.issn.1006-1959.2018.19.030]
[5]李跃飞,郑晶晶,于聪祥.干细胞标记物Musashi-1与子宫内膜异位症关系的研究进展[J].医学信息,2018,31(23):48.[doi:10.3969/j.issn.1006-1959.2018.23.014]
LI Yue-fei,ZHENG Jing-jing,YU Cong-xiang.Advances in Research on the Relationship between Cell Marker Musashi-1 and Endometriosis[J].Medical Information,2018,31(09):48.[doi:10.3969/j.issn.1006-1959.2018.23.014]
[6]邬素珍,许焕英,陈 玉,等.子宫内膜异位症痛经患者体质分布规律研究[J].医学信息,2019,32(15):80.[doi:10.3969/j.issn.1006-1959.2019.15.025]
WU Su-zhen,XU Huan-ying,CHEN Yu,et al.Study on the Distribution Law of Dysmenorrhea in Patients with Endometriosis[J].Medical Information,2019,32(09):80.[doi:10.3969/j.issn.1006-1959.2019.15.025]
[7]陈 玉,邬素珍,朱巧玲.子宫内膜异位症痛经患者情志状况的临床观察[J].医学信息,2020,33(01):106.[doi:10.3969/j.issn.1006-1959.2020.01.032]
CHEN Yu,WU Su-zhen,ZHU Qiao-ling.Clinical Observation of Emotional Status in Patients with Endometriosis Dysmenorrhea[J].Medical Information,2020,33(09):106.[doi:10.3969/j.issn.1006-1959.2020.01.032]
[8]李国馨.妇科因素所致慢性盆腔痛的研究[J].医学信息,2020,33(05):59.[doi:10.3969/j.issn.1006-1959.2020.05.018]
LI Guo-xin.Study on Chronic Pelvic Pain Caused by Gynecological Factors[J].Medical Information,2020,33(09):59.[doi:10.3969/j.issn.1006-1959.2020.05.018]
[9]杜 娟.亮丙瑞林治疗子宫内膜异位症伴不孕的应用[J].医学信息,2020,33(13):43.[doi:10.3969/j.issn.1006-1959.2020.13.012]
DU Juan.Application of Leuprolide in the Treatment of Endometriosis with Infertility[J].Medical Information,2020,33(09):43.[doi:10.3969/j.issn.1006-1959.2020.13.012]
[10]李昌秀,黄 婷.直肠子宫内膜异位症1例报道[J].医学信息,2020,33(17):191.[doi:10.3969/j.issn.1006-1959.2020.17.060]
[11]刘秀娟,刘 辉.子宫内膜异位症相关性不孕的诊断及治疗研究[J].医学信息,2018,31(14):35.[doi:10.3969/j.issn.1006-1959.2018.14.012]
LIU Xiu-juan,LIU Hui.Diagnosis and Treatment of Endometriosis Related Infertility[J].Medical Information,2018,31(09):35.[doi:10.3969/j.issn.1006-1959.2018.14.012]
[12]覃 璧,韦霁芸,石德敏,等.不同促排卵方案在子宫内膜异位症合并不孕患者体外受精治疗中的效果比较[J].医学信息,2022,35(08):118.[doi:10.3969/j.issn.1006-1959.2022.08.029]
QIN Bi,WEI Ji-yun,SHI De-min,et al.Comparison of the Effects of Different Ovulation Induction Regimens on In Vitro Fertilization in Patients with Endometriosis Complicated with Infertility[J].Medical Information,2022,35(09):118.[doi:10.3969/j.issn.1006-1959.2022.08.029]